(Q38228621)

31 August 2017

1 reference

title

The role of the blood-brain barrier in the aetiology of permanent brain dysfunction in hyperphenylalaninaemia (English)

1 reference

31 August 2017

1 reference

F A Hommes

1

1 reference

31 August 2017

1 January 1989

1 reference

Journal of Inherited Metabolic Disease

31 August 2017

1 reference

31 August 2017

12

1 reference

31 August 2017

1

1 reference

31 August 2017

41-46

1 reference

https://scigraph.springernature.com/pub.10.1007/bf01805529

31 August 2017

0 references

cites work

Where do the depleted plasma amino acids go in phenylketonuria?

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF01805529

Molecular Democracy: Who Shares the Controls?

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF01805529

Brain uptake of selenomethionine Se 75. II. Reduced brain uptake of selenomethionine Se 75 in phenylketonuria.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF01805529

Follow-up study of a nation-wide neonatal metabolic screening program in Japan. A collaborative study group of neonatal screening for inborn errors of metabolism in Japan

21 January 2018

1 reference

12 December 2020

Progress in experimental phenylketonuria: a critical review

1 reference

12 December 2020

A new approach to the treatment of phenylketonuria.

1 reference

12 December 2020

Large doses of tryptophan and tyrosine as potential therapeutic alternative to dietary phenylalanine restriction in phenylketonuria

1 reference

12 December 2020

Brain metabolism: a perspective from the blood-brain barrier

1 reference

12 December 2020

Reduction of cerebrospinal fluid phenylalanine after oral administration of valine, isoleucine, and leucine

1 reference

12 December 2020

On the pathogenesis of feeble-mindedness in phenylketonuria

1 reference

12 December 2020

Brain protein and myelin metabolism in hyperphenylalaninemic rats

1 reference

12 December 2020

Neutral amino acid transport at the human blood-brain barrier

1 reference

12 December 2020

Histidinaemia. Part II: Impact; a retrospective study.

1 reference

12 December 2020

Biochemical and neuropsychological effects of elevated plasma phenylalanine in patients with treated phenylketonuria. A model for the study of phenylalanine and brain function in man

1 reference

12 December 2020

Effect of experimental hyperphenylalaninemia on myelin metabolism at later stages of brain development.

1 reference

12 December 2020

Decreased vigilance and neurotransmitter synthesis after discontinuation of dietary treatment for phenylketonuria in adolescents.

1 reference

12 December 2020

Preliminary support for the oral administration of valine, isoleucine and leucine for phenylketonuria.

1 reference

12 December 2020

Turnover of the fast components of myelin and myelin proteins in experimental hyperphenylalaninaemia. Relevance to termination of dietary treatment in human phenylketonuria.

1 reference

12 December 2020

Phenylalanine alters the mean power frequency of electroencephalograms and plasma L-dopa in treated patients with phenylketonuria.

1 reference

12 December 2020

Serotonin and Dopamine Synthesis in Phenylketonuria

1 reference

12 December 2020

Increased Vigilance and Dopamine Synthesis by Large Doses of Tyrosine or Phenylalanine Restriction in Phenylketonuria

1 reference

12 December 2020

The effects of high phenylalanine concentrations on serotinin and catecholamine metabolism in the human brain

1 reference

12 December 2020

Successful long term therapy of biopterin deficiency

1 reference

12 December 2020

Histidinaemia. Part III: Impact; a prospective study

1 reference

12 December 2020

Inhibition of entry of some amino acids into the brain, with observations on mental retardation in the aminoacidurias

1 reference

12 December 2020

Intellectual development in patients with untreated histidinemia. A collaborative study group of neonatal screening for inborn errors of metabolism in Japan

1 reference

12 December 2020

Histidinaemia. Part I: Reconciling retrospective and prospective findings

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01805529

1 reference

PubMed ID

2501582

Dimensions Publication ID

31 August 2017

0 references

1 reference

PubMed ID

2501582